Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBC Lifespan in Diabetic Children
NCT03073070Phase 1Completed
- Start
- Nov 2017
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms). Primary endpoint: Red Blood Cell Survival at 120 days. Started Nov 2017; status: completed.
Beyond the preview
Go deeper on NCT03073070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073070.